The enhancer model must however also be compatible with CDKN1C silencing observed in BWS patients with epigenetic defects within the KvDMR including loss of maternal methylation (LOM) described here and in Diaz-Meyer et al [24]. This evidence concerns the gene CDKN1C and Beckwith-Wiedemann syndrome.